CTRI/2010/091/000037招募中3 期
WEEKLY PACLITAXEL IN COMBINATION WITH CARBOPLATIN EVERY 3 WEEKS FOR ADVANCED EPITHELIAL OVARIAN CANCER: A PHASE 3 RANDOMIZED STUDY
Department of Biotechnology Ministry of Science and Technology0 个研究点目标入组 270 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 270
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •a)Cytology proven epithelial ovarian carcinoma, FIGO stage III-IV
- •b)Age 18-70 years
- •c)ECOG performance status 0-2
- •d)Adequate Haemogram
- •e)Adequate renal and liver function tests
- •f)Willing to participate in the study
排除标准
- •a)Patients previously treated with chemotherapy or radiotherapy
- •b)Pregnancy and lactation
- •c)Cardiac illness (patients with ejection fraction less than 45%)
- •d)Pre-existing neuropathy
研究者
相似试验
进行中（未招募）
不适用
WEEKLY vs EVERY 3 WEEK CARBOPLATIN + PACLITAXEL IN PATIENTS WITH OVARIAN CANCER: RANDOMIZED MULTICENTER STUDY - MITO-7EUCTR2008-001754-40-ITISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE
终止
4 期
Weekly Carboplatin and Taxol with concurrent radiotherapy for locally advanced non small cell lung : Predictive factors for completion of treatment.ACTRN12607000043437South Eastern Illawarra Area Health service45
招募中
2 期
Phase II study of Weekly Paclitaxel+Weekly Carboplatin for Platinum/Taxan sensitive recurrent mullerian carcinomaJPRN-UMIN000003476Japan Kanto Tumor Board(JKTB)65
招募中
不适用
Weekly nab-Paclitaxel+Carboplatin with Radiotherapy as First Line Therapy in Patients with Advanced Non-Small-Cell Lung Canceron-Small-Cell Lung CancerJPRN-UMIN000031017niversity of Fukui Faculty of Medical Sciences25
已完成
2 期
Phase II study of Carboplatin, weekly Paclitaxel and Bevacizumab in elderly patients with advanced non-squamous non-small-cell lung cancer (NEJ 016)non-small cell lung cancerJPRN-UMIN000006622orth East Japan Study Group36